mortality analysis
Recently Published Documents


TOTAL DOCUMENTS

310
(FIVE YEARS 90)

H-INDEX

31
(FIVE YEARS 4)

Author(s):  
Jimmy T. Efird ◽  
Ethan J. Anderson ◽  
Charulata Jindal ◽  
Thomas S. Redding ◽  
Andrew D. Thompson ◽  
...  

This data-based cohort consisted of 26,508 (7%) United States veterans out of the 399,290 who tested positive for SARS-CoV-2 from 1 March to 10 September 2020. We aimed to assess the interaction of post-index vitamin D (Vit D) and corticosteroid (CRT) use on 30-day mortality among hospitalized and non-hospitalized patients with coronavirus disease 2019 (COVID-19). Combination Vit D and CRT drug use was assessed according to four multinomial pairs (−|+, −|−, +|+, +|−). Respective categorical effects were computed on a log-binomial scale as adjusted relative risk (aRR). Approximately 6% of veterans who tested positive for SARS-CoV-2 died within 30 days of their index date. Among hospitalized patients, a significantly decreased aRR was observed for the use of Vit D in the absence of CRTs relative to patients who received CRTs but not Vit D (aRR = 0.30; multiplicity corrected, p = 0.0004). Among patients receiving systemically administered CRTs (e.g., dexamethasone), the use of Vit D was associated with fewer deaths in hospitalized patients (aRR = 0.51) compared with non-hospitalized patients (aRR = 2.5) (P-for-Interaction = 0.0071). Evaluating the effect of modification of these compounds in the context of hospitalization may aid in the management of COVID-19 and provide a better understanding of the pathophysiological mechanisms underlying this and future infectious disease outbreaks.


2021 ◽  
Vol 61 (4) ◽  
pp. 483-491
Author(s):  
Nancy S. Donelan-McCall ◽  
Michael D. Knudtson ◽  
David L. Olds

2021 ◽  
Vol 25 (10) ◽  
pp. 1209-1209
Author(s):  
Saurabh Saigal ◽  
Abhijeet Anand ◽  
Rajesh Panda ◽  
Saiteja Kodamanchili ◽  
Krishnkant Bhardwaj ◽  
...  

2021 ◽  
Author(s):  
Susumu Annaka

Some scholars argue that democratic countries are in crisis during the COVID-19 pandemic and authoritarian countries tend to combat COVID-19. However, these studies are usually based on reported data susceptible to manipulation and often overlook successful cases such as New Zealand and Taiwan, which are considered to have higher levels of government effectiveness. Using excess mortality data from 78 countries, this study analyzed the impact of government effectiveness and its relationship with political regimes. The results revealed that democratic countries with higher government effectiveness can reduce COVID-19 excess mortality. This study suggests that democratic countries need not give up freedom and need to improve government effectiveness to combat COVID-19.


Author(s):  
Sean P. Lyden ◽  
Marianne Brodmann ◽  
Sahil A. Parikh ◽  
Prakash Krishnan ◽  
Henrik Schroeder ◽  
...  

2021 ◽  
Author(s):  
Markus Meier ◽  
Anna Utte ◽  
Emma Smith ◽  
Peter Färber ◽  
Marko Staben ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document